Gheuens Sarah plan to sell securities of AGIOS PHARMACEUTICALS, INC. under Form 144

Gheuens Sarah filed Form 144 to notify SEC of plan to sell 4007 units of AGIOS PHARMACEUTICALS, INC. securities around 2026-07-01, with aggregate market value of $150,502.92. The total outstanding units is 59471609.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 months include: On 04/02/2026, sold 2940 units for $102047.40;